Uptake of the culturally appropriate ASQ‐TRAK developmental screening tool in the Australian Aboriginal and Torres Strait Islander context

D’Aprano, Anita; Brookes, Isabel; Browne, Linda; Bartlett, Claire

doi:10.1111/cch.13006

Cited by 5 publications

(6 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Given that there is a variety of diverse Aboriginal and Torres Strait Islander communities (i.e., different cultures and different languages spoken) that live in all parts of Australia [ 42 ], more research, which encompasses a broad scope of Aboriginal and Torres Strait Islander communities’ needs, are to be undertaken to determine the generalisability of the ASQ-TRAK for use with all Aboriginal and Torres Strait Islander children. Additional research on the ASQ-TRAK may also help increase the uptake of the measure, with recent research showing that despite the promising evidence, most Aboriginal Community Controlled Organisations have not yet accessed the tool or its training [ 43 ]. Furthermore, it is important to reiterate that the ASQ-TRAK only has evidence for use with First Nations children in Australia, and the results are therefore not generalisable to First Nations children internationally.…”

Section: Discussionmentioning

confidence: 99%

Developmental Screening Tools Used with First Nations Populations: A Systematic Review

Cibralic

Hawker

Khan

et al. 2022

IJERPH

View full text Add to dashboard Cite

Developmental surveillance and screening is recommended for all children under five years of age, especially for those from at-risk populations such as First Nations children. No review to date has, however, evaluated the use of developmental screening tools with First Nations children. This review aimed to examine and synthesise the literature on developmental screening tools developed for, or used with, First Nations populations children aged five years or younger. A PRISMA-compliant systematic review was performed in the PsychInfo, PubMed, and Embase databases. Additional searches were also undertaken. In total 444 articles were identified and 13 were included in the final review. Findings indicated that several developmental screening tools have been administered with First Nations children. Most tools, however, have only been evaluated in one study. Results also found that no studies evaluated actions taken following positive screening results. More research evaluating the accuracy, acceptability, and feasibility of using developmental screeners with First Nations children is required before widespread implementation of developmental screening in clinical settings with First Nations children is recommended.

show abstract

Section: Discussionmentioning

confidence: 99%

Developmental Screening Tools Used with First Nations Populations: A Systematic Review

Cibralic

Hawker

Khan

et al. 2022

IJERPH

View full text Add to dashboard Cite

show abstract

“…24 Uptake of this tool, which requires purchase, is still far from universal across the ACCHS sector, with 8 of 20 ACCHS in WA having purchased the tool as of 2022. 25 ECD practices were largely provided opportunistically but were also included in four-fifths of the federal-funded MBS 715 health checks. Given the importance of MBS 715 health checks, better integration of ECD tools with health assessment templates would likely increase developmental monitoring coverage.…”

Section: Discussionmentioning

confidence: 99%

“…Since the interviews for this study were completed, the ASQ‐TRAK tool has been validated as a culturally appropriate adaptation of the Ages and Stages Questionnaire (ASQ‐3) for developmental screening for Australian Aboriginal Children 24 . Uptake of this tool, which requires purchase, is still far from universal across the ACCHS sector, with 8 of 20 ACCHS in WA having purchased the tool as of 2022 25 …”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Early childhood development practices in a remote Aboriginal Community Controlled Health Services setting

Bromley

Sherrard

Atkinson

et al. 2022

Australian J Rural Health

View full text Add to dashboard Cite

Objective Supporting Early Childhood Development (ECD) is an Australian national priority. Aboriginal children in Western Australia's Kimberley region have much higher rates of developmental concerns at school entry than non‐Aboriginal children. We aimed to describe ECD practices in the participating service; document follow‐up of identified developmental concerns; and identify barriers and enablers to incorporating ECD practices into clinic activity. Design Mixed‐method design incorporating clinical audit and staff interviews. Setting An Aboriginal Community Controlled Health Service (ACCHS) in the Kimberley region. Participants A total of 176 children receiving primary health care through the participating ACCHS; interviews with five ACCHS staff members. Main outcome measures Frequency of developmental enquiry by age and domain; follow‐up of identified developmental concerns; and barriers and enablers to ECD practices. Results Developmental enquiry was documented for 114 of 176 eligible children (65%), including in 80% of ACCHS child health assessments. Standardised ECD assessments were less common. Staff were aware of the importance of developmental enquiry, however, barriers to increasing ECD practices included a lack of resources and structured staff education, time pressures and a lack of role clarity between the ACCHS and government community health clinic. Conclusions This study provides insight into ECD practices in an ACCHS setting, highlighting the potential of primary health care to have an enhanced role in ECD if appropriate systems, training and tools are provided. A lack of role clarity across services, combined with poor communication between services, creates a potential risk for missed opportunities to support ECD.

show abstract

“…Scores are compared with domain specific cut-offs to determine risk of developmental delay, with further assessment recommended for infants who score below the cut-off, or ‘at risk’, for any domain. 121 The ASQ-TRAK has proven face validity and was determined to be culturally relevant and acceptable by Aboriginal healthcare workers and parents. 122 123 The screener takes 30–60 min to complete and can be administered by trained healthcare workers.…”

Section: Methodsmentioning

confidence: 99%

Early detection of Australian Aboriginal and Torres Strait Islander infants at high risk of adverse neurodevelopmental outcomes at 12 months corrected age: LEAP-CP prospective cohort study protocol

et al. 2022

View full text Add to dashboard Cite

IntroductionNeurodevelopmental disorders (NDD), including cerebral palsy (CP), autism spectrum disorder (ASD) and foetal alcohol spectrum disorder (FASD), are characterised by impaired development of the early central nervous system, impacting cognitive and/or physical function. Early detection of NDD enables infants to be fast-tracked to early intervention services, optimising outcomes. Aboriginal and Torres Strait Islander infants may experience early life factors increasing their risk of neurodevelopmental vulnerability, which persist into later childhood, further compounding the health inequities experienced by First Nations peoples in Australia. The LEAP-CP prospective cohort study will investigate the efficacy of early screening programmes, implemented in Queensland, Australia to earlier identify Aboriginal and Torres Strait Islander infants who are ‘at risk’ of adverse neurodevelopmental outcomes (NDO) or NDD. Diagnostic accuracy and feasibility of early detection tools for identifying infants ‘at risk’ of a later diagnosis of adverse NDO or NDD will be determined.Methods and analysisAboriginal and/or Torres Strait Islander infants born in Queensland, Australia (birth years 2020–2022) will be invited to participate. Infants aged <9 months corrected age (CA) will undergo screening using the (1) General Movements Assessment (GMA); (2) Hammersmith Infant Neurological Examination (HINE); (3) Rapid Neurodevelopmental Assessment (RNDA) and (4) Ages and Stages Questionnaire-Aboriginal adaptation (ASQ-TRAK). Developmental outcomes at 12 months CA will be determined for: (1) neurological (HINE); (2) motor (Peabody Developmental Motor Scales 2); (3) cognitive and communication (Bayley Scales of Infant Development III); (4) functional capabilities (Paediatric Evaluation of Disability Inventory-Computer Adaptive Test) and (5) behaviour (Infant Toddler Social and Emotional Assessment). Infants will be classified as typically developing or ‘at risk’ of an adverse NDO and/or specific NDD based on symptomology using developmental and diagnostic outcomes for (1) CP (2) ASD and (3) FASD. The effects of perinatal, social and environmental factors, caregiver mental health and clinical neuroimaging on NDOs will be investigated.Ethics and disseminationEthics approval has been granted by appropriate Queensland ethics committees; Far North Queensland Health Research Ethics Committee (HREC/2019/QCH/50533 (Sep ver 2)-1370), the Townsville HHS Human Research Ethics Committee (HREC/QTHS/56008), the University of Queensland Medical Research Ethics Committee (2020000185/HREC/2019/QCH/50533) and the Children’s Health Queensland HHS Human Research Ethics Committee (HREC/20/QCHQ/63906) with governance and support from local First Nations communities. Findings from this study will be disseminated via peer-reviewed publications and conference presentations.Trial registration numberACTRN12619000969167.

show abstract

Uptake of the culturally appropriate ASQ‐TRAK developmental screening tool in the Australian Aboriginal and Torres Strait Islander context

Cited by 5 publications

References 24 publications

Developmental Screening Tools Used with First Nations Populations: A Systematic Review

Developmental Screening Tools Used with First Nations Populations: A Systematic Review

Early childhood development practices in a remote Aboriginal Community Controlled Health Services setting

Early detection of Australian Aboriginal and Torres Strait Islander infants at high risk of adverse neurodevelopmental outcomes at 12 months corrected age: LEAP-CP prospective cohort study protocol

Contact Info

Product

Resources

About